Jamjoom Pharma completes Pfizer facility acquisition in Saudi Arabia
- Source
- Argaam - Company Disclosures
- Source link
- https://www.argaam.com/en/article/articledetail/id/1930027
- Published
- 2026-08-17 17:02:00
- Discovered by ProcIntel
- 2026-08-17 14:37:03
- Category
- Supplier Risk
- Geography
- Saudi Arabia, UAE
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
<p><img src="https://argaamplus.s3.amazonaws.com/169f02e8-3bab-451e-a491-c822e1c461bf.png" ></p> <p class="ckeCaption" >Logo ofJamjoom Pharma</p> <hr> <p >Jamjoom Pharmaceuticals Factory Co. (<a href="https://www.argaam.com/en/tadawul/tasi/jamjoom-pharma" target="_blank">Jamjoom Pharma</a>) completed on Aug. 16, its acquisition of a pharmaceutical manufacturing facility located in King Abdullah Economic City, Saudi Arabia, from Pfizer Saudi Limited, the company announced yesterday.</p> <p ></p> <p >The facility specializes in manufacturing and packaging oral solid dosage (OSD) medicines, covering the full production process and supported by fully integrated on-site quality control laboratories, and is now part of Jamjoom Pharma’s manufacturing network, according to a company statement.</p> <p ></p> <p >The company said the acquisition was completed following the signing of the facility’s sale and purchase agreement on April 26, 2026, and the fulfillment of customary conditions precedent, including obtaining the necessary regulatory approvals.</p>
Procurement Relevance Gate
- supplier_or_company_impact (weight 12) — matched on "acquisition"
- capacity_production_disruption (weight 12) — matched on "factory"
- geographic_exposure (weight 8) — matched on "2 linked geographies"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
- Initial Significance
- 2 · Moderate (35.0/100)
- Initial Confidence
- 2 · Low (23.5/100)
- Data sufficiency Whether enough structured evidence exists to trust this Signal's Initial Confidence reading. 'Sufficient' has no cap; 'Partial' and 'Insufficient' cap Confidence until more evidence is available; 'Not Assessed' means the Signal did not pass the Relevance Gate.
- Partial
- Strongest contributor
- Procurement Impact
- Limiting factor
- Geographic Breadth
Initial Significance Moderate (35.0/100). Strongest contributor: Procurement Impact (27.0/30 points). Limiting factor: Geographic Breadth (0.0/10 points). Initial Confidence Low (23.5/100, data sufficiency: Partial). Strongest contributor: Source Authority (12.0/40 points). Limiting factor: Corroboration (2.5/25 points).
- No likely Event type matched; a low contextual baseline was applied.
- No eligible (non-geographic, non-fictional) entities were linked to this Signal.
- no matched Event type
- no actor entities (only attribution/metadata, if any)
- no actor content-derived geography
- single source only
- Only source-level entity metadata was available.
- Only source-level geography metadata was available.
- Source metadata did not contribute to Initial Confidence.
Methodology signal_scoring_v1 — calculated 2026-08-17 14:37:03.